All advisers

SEC-Registered Investment Adviser

Kildare Partners US, LLC

CRD 167984

Registration facts are from the firm's Form ADV Part 1A as published by the SEC, latest filing dated March 26, 2026. Figures are firm-level: they describe the advisory firm, not any single offering.

Registration

Status
Approved
Registered since
September 16, 2013
Principal office
1301 Solana Blvd., Building 2, Suite 2300, Westlake, TX 76262
Organized as
Limited Liability Company, DE
Fiscal year end
December
Umbrella registration
Yes, 8 relying advisers
Full record on SEC IAPD

Scale

Regulatory AUM
$1.9B
Attributable to non-US clients
$1.2B
Accounts
16
Clients
0
Employees
40, 24 in advisory roles
Private funds advised
10
Private fund gross assets
$1.5B
Fund types
10 real estate funds
Funds with Form D records
4 issuers in AltStreet's ledger, $1.5B reported sold across them

Business, clients and compensation, as filed

Advisory activities
portfolio management for pooled investment vehicles
Compensated by
a percentage of assets under management, performance-based fees and other
Client types
pooled investment vehicles (16)
Related persons include
a commodity pool operator or commodity trading advisor, a sponsor or syndicator of limited partnerships and a sponsor, general partner or managing member of pooled investment vehicles

Form ADV Item 11 disclosures

No yes answers on Item 11 as of the latest Form ADV (March 26, 2026). Item 11 covers the firm and its advisory affiliates.

Is this your firm? Verified Profiles give managers a structured channel for corrections, additional disclosures, and right of reply, without changing AltStreet's independent research. Learn about verification →

Source: SEC Form ADV via IARD (roster of October 6, 2026), matched to the platform by AltStreet analysts. Item 11 answers are as reported on the firm's Form ADV and cover the firm and its advisory affiliates; consult the firm's IAPD record for the Disclosure Reporting Pages. Brochure statements are the firm's own. Nothing on this page is investment advice.